Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMenéndez, Clara-
dc.contributor.authorBardají, Azucena-
dc.contributor.authorSigauque, Betuel-
dc.contributor.authorRomagosa Pérez-Portabella, Cleofé-
dc.contributor.authorSanz, Sergi-
dc.contributor.authorSerra-Casas, Elisa-
dc.contributor.authorMacete, Eusébio-
dc.contributor.authorBerenguera, Anna-
dc.contributor.authorDavid, Catarina-
dc.contributor.authorDobaño, Carlota, 1969--
dc.contributor.authorNaniche, Denise-
dc.contributor.authorMayor Aparicio, Alfredo Gabriel-
dc.contributor.authorOrdi i Majà, Jaume-
dc.contributor.authorMandomando, Inácio-
dc.contributor.authorAponte, John J.-
dc.contributor.authorMabunda, Samuel-
dc.contributor.authorAlonso, Pedro-
dc.description.abstractBackground:Current recommendations to prevent malaria in African pregnant women rely on insecticide treated nets(ITNs) and intermittent preventive treatment (IPTp). However, there is no information on the safety and efficacy of theircombined use.Methods:1030 pregnant Mozambican women of all gravidities received a long-lasting ITN during antenatal clinic (ANC)visits and, irrespective of HIV status, were enrolled in a randomised, double blind, placebo-controlled trial, to assess thesafety and efficacy of 2-dose sulphadoxine-pyrimethamine (SP). The main outcome was the reduction in low birth weight.Findings:Two-dose SP was safe and well tolerated, but was not associated with reductions in anaemia prevalence atdelivery (RR, 0.92 [95% CI, 0.79-1.08]), low birth weight (RR, 0.99 [95% CI, 0.70-1.39]), or overall placental infection(p = 0.964). However, the SP group showed a 40% reduction (95% CI, 7.40-61.20]; p = 0.020) in the incidence of clinicalmalaria during pregnancy, and reductions in the prevalence of peripheral parasitaemia (7.10% vs 15.15%) (p,0.001), and ofactively infected placentas (7.04% vs 13.60%) (p = 0.002). There was a reduction in severe anaemia at delivery of borderlinestatistical significance (p = 0.055). These effects were not modified by gravidity or HIV status. Reported ITN's use was morethan 90% in both groups.Conclusions:Two-dose SP was associated with a reduction in some indicators, but these were not translated to significantimprovement in other maternal or birth outcomes. The use of ITNs during pregnancy may reduce the need to administerIPTp. ITNs should be part of the ANC package in sub-Saharan Africa-
dc.format.extent9 p.-
dc.publisherPublic Library of Science (PLoS)-
dc.relation.isformatofReproducció del document publicat a:
dc.relation.ispartofPLoS One, 2008, vol. 3, num. 4, p. e1934-
dc.rightscc-by (c) Menéndez, et al., 2008-
dc.subject.classificationAssaigs clínics-
dc.subject.classificationÀfrica subsahariana-
dc.subject.otherPregnant women-
dc.subject.otherPlacebos (Medicine)-
dc.subject.otherClinical trials-
dc.subject.otherSub-Saharan Africa-
dc.titleA randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic-
Appears in Collections:Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
573164.pdf202.47 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons